HEALTH

Health Articles

PharmAla Biotech $MDMA Investor Ecstasy Just Beginning

PharmAla Biotech $MDMA Investor Ecstasy Just Beginning

PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...

read more
iologo

Subscribe - News Letter

6 + 1 =